Blurring of vision as the only symptom in an undiagnosed case of chronic myeloid leukemia in the COVID-19 era.

Gumaste, Priyanka; Vairagyam, Rajalingam

Gumaste, Priyanka; Vairagyam, Rajalingam.

Gumaste P; Sarojini Devi Eye Hospital, Osmania Medical College, Hyderabad, Telangana, India.
Vairagyam R; Sarojini Devi Eye Hospital, Osmania Medical College, Hyderabad, Telangana, India.

Indian J Ophthalmol ; 69(3): 768-769, 2021 Mar.

Article in English | MEDLINE | ID: covidwho-1089044

Subject(s)

COVID-19/epidemiology; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/complications; Retinal Hemorrhage/etiology; Visual Acuity; Adult; Comorbidity; Diagnosis, Differential; Fluorescein Angiography/methods; Fundus Oculi; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/epidemiology; Male; Retinal Hemorrhage/diagnosis; Retinal Hemorrhage/epidemiology; SARS-CoV-2; Tomography, Optical Coherence/methods

Keywords

CML; Nepafenac eyedrops; Roth spots; Submacular hemorrhage; T. Dasatinib

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Retinal Hemorrhage / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Visual Acuity / COVID-19 Type of study: Case report / Diagnostic study / Observational study Topics: Long Covid Limits: Adult / Humans / Male Language: English Journal: Indian J Ophthalmol Year: 2021 Document Type: Article Affiliation country: Ijo.IJO_3629_20

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google